Industry Outlook
The coenzyme A market will showcase impressive growth at a compounded annual growth rate (CAGR) of 8.1% during the forecast period from 2018 to 2026. Coenzyme A is an important biomolecule which has prominent significance in the enzymatic acyl group transfer reactions pertaining to oxidation and synthesis of fatty acids. It is also an important cofactor in several biochemical enzymatic reactions such as kreb cycle and cell replication. The derivatives of coenzyme A are easily synthesized in chemical laboratories. Therapeutic importance of coenzyme A is related to promote cellular respiration, mitochondrial repair diet and increase fat burning enzymes. Increasing biotechnology research and recent technological advancement in food and nutrition science have a positive influence in the coenzyme A market growth.
Market Synopsis
Get a sample copy for more information
"Enhanced stability and inert nature increases the popularity of lithium salt in biochemical reactions"
lithium salts are leading the type segment for coenzyme A market. The factors responsible for the enhanced popularity of trilithium salts are it increases the chemical stability and inert nature of coenzyme A at room temperature. It is widely used in biomedicine research areas pertaining to immunology & inflammation and cell biology. Sodium salt derivatives of coenzyme A have tremendous application in dietary supplement and energy drinks due to its enhanced solubility in aqueous solution and increased ion exchange rate at cellular level.
Get a sample copy for more information
"Significance of coenzyme A as an important cofactor in biochemical intermediary metabolism drive the biotechnology research market"
At present biotechnology research is reigning the application segment for coenzyme A market. The significant role of coenzyme A as an important cofactor in a number of biosynthetic and oxidative intermediary metabolism drive the biotechnology research market growth. It is noteworthy that coenzyme A and its derivatives can be successfully produced by employing biotechnology research. It has gained prominent significance in pharmaceutical industry due to its ability to extend the medication half-life and prolong the pharmacodynamics effect of drug molecule at the receptor level. Dietary supplement will be highlighting excellent growth during the forecast period owing to its importance in synthesizing fatty acids which maintain the integrity of cell membranes. Coenzyme A is also incorporated in energy drinks to accelerate the production of energy rich compound ATP which is a prerequisite for production of proteins and deoxyribonucleic acid to promote cell replication.
Get a sample copy for more information
"Increasing biotechnology research and flourishing dietary supplement industry drive the coenzyme A market in North America"
In the current scenario North America is the clear leader in the regional segment for coenzyme A market. The key parameters engaged are flourishing dietary supplement industry and increasing biotechnology research. According to research findings of Center for Disease Control and Prevention (CDC), chronic diseases can be prevented by modulating the biochemical processes of human body and regular intake of dietary supplement enriched with useful coenzymes. In Europe the coenzyme A market growth is driven by rising public health awareness and domicile of major players such as Merck KGaA, SigmaAldrich and DSM etc. Asia Pacific will be the fastest growing geographical segment during the forecast period on account of increasing number of patients suffering with metabolic disorders and malnourishment in children. Rapid growth in local suppliers exert a competitive scenario for key players which has an impetus for the coenzyme A market growth in Asia Pacific.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.
Report Scope by Segments
The segmentation for the report titled coenzyme A market is considered as follows:
| ATTRIBUTE |
DETAILS |
| Research Period |
2016-2026 |
| Base Year |
2017 |
| Forecast Period |
2018-2026 |
| Historical Year |
2016 |
| Unit |
USD Million |
| Segmentation |
By Type Segment (2016-2026; US$ Mn)
• Lithium Salt
• Sodium Salt
• Free Acid
• Others
|
|
By Application Segment (2016-2026; US$ Mn)
• Biotechnology Research
• Dietary Supplement
• Therapeutic
• Others
|
|
Geography Segment (2016–2026; US$ Mn)
• North America (United States and Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (China, Japan, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East and Africa (GCC, Rest of MEA)
|
The biomolecules manufacturing companies present in the coenzyme A market are Avanti Polar Lipids, Inc., BASF, Cayman Chemical, Creative Enzymes, DSM, Lee BioSolutions, Inc., Merck KGaA, PerkinElmer, Inc., SigmaAldrich and Thermo Fisher Scientific, Inc.
Key questions answered in this report
- How are the organic and inorganic market growth strategies utilized to determine the market size and CAGR for coenzyme A market?
- What are the drivers, restraints and opportunities pertaining to coenzyme A market?
- What is the importance of coenzyme A in biochemical reaction and its benefit to human health?
- Which is the leading and fastest growing type segment for coenzyme A market?
- Which is the leading and fastest growing application segment for coenzyme A market?
- Which is the leading and fastest growing geographical segment for coenzyme A market?
